• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Understanding the clinical and demographic characteristics of second coronavirus spike in 192 patients in Tehran, Iran: A retrospective study.了解伊朗德黑兰 192 例患者中第二次冠状病毒爆发的临床和人口统计学特征:一项回顾性研究。
PLoS One. 2021 Mar 19;16(3):e0246314. doi: 10.1371/journal.pone.0246314. eCollection 2021.
2
Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences, Iran.伊朗马什哈德医科大学的一项横断面研究:严重 COVID-19 感染的人口统计学和临床特征。
BMC Infect Dis. 2021 Jul 7;21(1):656. doi: 10.1186/s12879-021-06363-6.
3
Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.伊朗克尔曼沙阿省 27256 例住院 COVID-19 患者的人口统计学、临床特征和结局:一项回顾性一年队列研究。
BMC Infect Dis. 2022 Mar 31;22(1):319. doi: 10.1186/s12879-022-07312-7.
4
Clinical Characteristics and Outcomes of 905 COVID-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran.德黑兰首都伊玛目霍梅尼医院综合大楼 905 例 COVID-19 患者的临床特征和结局。
Arch Iran Med. 2020 Nov 1;23(11):766-775. doi: 10.34172/aim.2020.102.
5
Infliximab and Intravenous Gammaglobulin in Hospitalized Severe COVID-19 Patients in Intensive Care Unit.英夫利昔单抗和静脉注射免疫球蛋白用于重症监护病房中住院的重症COVID-19患者
Arch Iran Med. 2021 Feb 1;24(2):139-143. doi: 10.34172/aim.2021.22.
6
Clinical characteristics and outcome of hospitalized COVID-19 patients with diabetes: A single-center, retrospective study in Iran.伊朗单中心回顾性研究:住院 COVID-19 合并糖尿病患者的临床特征和转归。
Diabetes Res Clin Pract. 2020 Nov;169:108467. doi: 10.1016/j.diabres.2020.108467. Epub 2020 Sep 24.
7
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
8
Clinical Presentation of Iranian Patients Affected with COVID-19: A Thousand Faces Disease.伊朗 COVID-19 患者的临床表现:千面疾病。
Iran J Allergy Asthma Immunol. 2021 Apr 17;20(2):140-146.
9
Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study.静脉注射免疫球蛋白辅助治疗重症 COVID-19:一项单中心回顾性队列研究。
Virol J. 2021 May 21;18(1):101. doi: 10.1186/s12985-021-01575-3.
10
Efficacy evaluation of intravenous immunoglobulin in non-severe patients with COVID-19: A retrospective cohort study based on propensity score matching.COVID-19 非重症患者静脉注射免疫球蛋白的疗效评价:基于倾向评分匹配的回顾性队列研究。
Int J Infect Dis. 2021 Apr;105:525-531. doi: 10.1016/j.ijid.2021.01.009. Epub 2021 Jan 9.

引用本文的文献

1
Obesity as an independent risk factor for COVID-19 severity and mortality.肥胖是 COVID-19 严重程度和死亡率的独立危险因素。
Cochrane Database Syst Rev. 2023 May 24;5(5):CD015201. doi: 10.1002/14651858.CD015201.
2
Comparison of the epidemiological features of COVID-19 patients in the first and second waves: A study from South India.新冠疫情第一波和第二波期间印度南部COVID-19患者流行病学特征比较研究
J Family Med Prim Care. 2023 Jan;12(1):133-138. doi: 10.4103/jfmpc.jfmpc_1172_22. Epub 2023 Feb 15.
3
A joint Bayesian spatiotemporal risk prediction model of COVID-19 incidence, IC admission, and death with application to Sweden.一种用于预测新冠病毒疾病发病率、重症监护病房收治率和死亡率的联合贝叶斯时空风险预测模型及其在瑞典的应用
Ann Reg Sci. 2022 Nov 28:1-34. doi: 10.1007/s00168-022-01191-1.
4
An opinion on Wastewater-Based Epidemiological Monitoring (WBEM) with Clinical Diagnostic Test (CDT) for detecting high-prevalence areas of community COVID-19 Infections.关于基于废水的流行病学监测(WBEM)与临床诊断测试(CDT)用于检测社区新冠病毒感染高流行区域的意见。
Curr Opin Environ Sci Health. 2022 Oct 6:100396. doi: 10.1016/j.coesh.2022.100396.
5
ICU strain and outcome in COVID-19 patients-A multicenter retrospective observational study.COVID-19 患者的 ICU 压力和结局-一项多中心回顾性观察研究。
PLoS One. 2022 Jul 19;17(7):e0271358. doi: 10.1371/journal.pone.0271358. eCollection 2022.

本文引用的文献

1
Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study.伊朗 2019 冠状病毒病(COVID-19)患者的流行病学特征:一项单中心研究。
J Clin Virol. 2020 Jun;127:104378. doi: 10.1016/j.jcv.2020.104378. Epub 2020 Apr 21.
2
Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019.1420 例轻症至中症 2019 年冠状病毒病欧洲患者的临床和流行病学特征。
J Intern Med. 2020 Sep;288(3):335-344. doi: 10.1111/joim.13089. Epub 2020 Jun 17.
3
Transmission Potential of Asymptomatic and Paucisymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections: A 3-Family Cluster Study in China.无症状和轻症严重急性呼吸综合征冠状病毒 2 感染的传播潜力:中国的 3 户家庭聚集性研究。
J Infect Dis. 2020 Jun 11;221(12):1948-1952. doi: 10.1093/infdis/jiaa206.
4
Covid-19 and Immunity in Aging Populations - A New Research Agenda.新冠疫情与老年人群的免疫力——一项新的研究议程。
N Engl J Med. 2020 Aug 27;383(9):804-805. doi: 10.1056/NEJMp2006761. Epub 2020 Apr 17.
5
The proximal origin of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的近端起源。
Nat Med. 2020 Apr;26(4):450-452. doi: 10.1038/s41591-020-0820-9.
6
Corticosteroid Guidance for Pregnancy during COVID-19 Pandemic.COVID-19 大流行期间妊娠期皮质类固醇使用指南。
Am J Perinatol. 2020 Jun;37(8):809-812. doi: 10.1055/s-0040-1709684. Epub 2020 Apr 9.
7
Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning.新冠(COVID-19)时期的思考:我们在新冠病毒致病机制、诊断、治疗及疫苗研发计划中的参与情况
Autoimmun Rev. 2020 Jun;19(6):102538. doi: 10.1016/j.autrev.2020.102538. Epub 2020 Apr 5.
8
The effectiveness of quarantine of Wuhan city against the Corona Virus Disease 2019 (COVID-19): A well-mixed SEIR model analysis.武汉市对 2019 年冠状病毒病(COVID-19)的隔离措施的有效性:一个混合 SEIR 模型分析。
J Med Virol. 2020 Jul;92(7):841-848. doi: 10.1002/jmv.25827. Epub 2020 Apr 25.
9
Coronavirus disease 2019 (COVID-19): current status and future perspectives.新型冠状病毒病 2019(COVID-19):现状和未来展望。
Int J Antimicrob Agents. 2020 May;55(5):105951. doi: 10.1016/j.ijantimicag.2020.105951. Epub 2020 Mar 29.
10
Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China.中国徐州 2 户家庭聚集性疫情中 SARS-CoV-2 的无症状传播和人际传播。
Emerg Infect Dis. 2020 Jul;26(7):1626-1628. doi: 10.3201/eid2607.200718. Epub 2020 Jun 21.

了解伊朗德黑兰 192 例患者中第二次冠状病毒爆发的临床和人口统计学特征:一项回顾性研究。

Understanding the clinical and demographic characteristics of second coronavirus spike in 192 patients in Tehran, Iran: A retrospective study.

机构信息

Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Department of Anesthesiology and Critical Care, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

出版信息

PLoS One. 2021 Mar 19;16(3):e0246314. doi: 10.1371/journal.pone.0246314. eCollection 2021.

DOI:10.1371/journal.pone.0246314
PMID:33739987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7979149/
Abstract

During the last months of the coronavirus pandemic, with all those public restrictions and health interventions, the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appears now to have been raised in some countries around the world. Iran was one of those first countries facing the second wave of coronavirus, due to the lack of appropriate public restrictions because of economic problems the country is facing. The clinical and demographic characteristics of severe cases and non-severe cases of Coronavirus Disease (COVID-19) in 192 patients in Tehran, Iran, between June 16 and July 11, 2020, were investigated. The patients were divided into severe cases (n = 82) and non-severe cases (n = 110). Demographic and clinical characteristics were compared between the two study clusters. The mean age was 54.6 ± 17.2 years, and the most common presenting symptom was persistent cough (81.8%) and fever (79.7%). The logistic regression model revealed that age, BMI, and affected family members were statistically associated with severity. Patients with complicated conditions of disorders faced more hospitalization days and medical care than the average statistical data. As the coronavirus spike in the case and death reports from June 2020, we observed the rise in the incidence of severe cases, where 42.7% (82/192) of cases have resulted in severe conditions. Our findings also suggested that the effect of IFB (Betamethasone) was more valid than the other alternative drugs such as LPV/r and IVIg.

摘要

在冠状病毒大流行的最后几个月,由于所有这些公共限制和卫生干预措施,严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的传播在世界上一些国家似乎有所增加。伊朗是最早面临冠状病毒第二波疫情的国家之一,由于该国面临的经济问题,缺乏适当的公共限制。2020 年 6 月 16 日至 7 月 11 日,对伊朗德黑兰 192 例冠状病毒疾病(COVID-19)重症和非重症患者的临床和人口统计学特征进行了调查。患者分为重症组(n=82)和非重症组(n=110)。比较了两组患者的人口统计学和临床特征。平均年龄为 54.6±17.2 岁,最常见的首发症状是持续性咳嗽(81.8%)和发热(79.7%)。逻辑回归模型显示,年龄、BMI 和受感染的家庭成员与严重程度有统计学关联。有并发症的患者住院天数和医疗护理比平均统计数据多。自 2020 年 6 月病例和死亡报告中的冠状病毒激增以来,我们观察到重症病例的发病率上升,其中 42.7%(82/192)的病例出现严重情况。我们的研究结果还表明,IFB(倍他米松)的效果比 LPV/r 和 IVIg 等其他替代药物更有效。